ALTERNATIVE COMPLEMENT PATHWAY PHARMACODYNAMICS OF IPTACOPAN
Back
Abstract Number
WCN23-0373
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
ALTERNATIVE COMPLEMENT PATHWAY PHARMACODYNAMICS OF IPTACOPAN
Co-authors
Schmouder, R.(1)*;Junge, G.(2);Milojevic, J.(3);Nidamarthy, P.K.(4);Kumatycki, K.(3);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Novartis Pharmaceuticals Corporation, Translational Medicine, East Hanover, United States;(2)Novartis Pharma Ag, Translational Medicine, Basel, Switzerland;(3)Novartis Institutes Of Biomedical Research, Translational Medicine, Cambridge, United States;(4)Novartis Healthcare Pvt. Ltd., Biostatistics & Pharmacometrics, Hyderabad, India;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/b78950b30a14eb6cb706915719298b95.pdf
Audio File
https://storage.unitedwebnetwork.com/files/1041/232d20192ebfbdc4945319c6961536df.mp3
if any